Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/a-global-study-led-by-cu-medicine-and-hkumed-discovers-a-hepatitis-c-virus-drug-as-potent-treatment-for-covid-19
https://www.med.cuhk.edu.hk/press-releases/a-global-study-led-by-cu-medicine-and-hkumed-discovers-a-hepatitis-c-virus-drug-as-potent-treatment-for-covid-19

A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19

Research team

A recent global study led by researchers from CU Medicine and HKUMed has discovered a hepatitis C virus drug “simeprevir” as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug with remdesivir can result in drug synergism and generate an even more effective outcome.

(From right) Professor David Shu Cheong HUI, Stanley Ho Professor of Respiratory Medicine and Professor Billy Wai Lung NG, Assistant Professor of the School of Pharmacy at CU Medicine; Associate Professor Dr. Michael Chi Wai CHAN and Research Assistant Professor Dr. Kenrie Pui Yan HUI of the School of Public Health at HKUMed.

A recent global study led by researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) and the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) has discovered a hepatitis C virus drug “simeprevir” as a potent treatment for COVID-19, which can strongly suppress the replication of SARS-CoV-2. The combination of this drug with remdesivir can result in drug synergism and generate an even more effective outcome. Simeprevir is by now the only antiviral drug that can target more than one SARS-CoV-2 protein, meaning it can still function even if one of the proteins becomes mutated. The drug has great therapeutic potential and with less chance to develop drug-resistant mutants. The results from this cellular model study have been published in a leading international chemistry journal ACS Central Science
Simeprevir targets two SARS-CoV-2 proteins

 

Since the beginning of 2020, Professor Billy Wai Lung NG from CU Medicine and Dr Michael Chi Wai CHAN from HKUMed have collaborated with over 30 scientists from local and overseas laboratories (including the Mainland, the U.S., France, Germany, South Korea and Taiwan) to search for an effective drug molecule for the treatment of COVID-19. Using a combination of biochemistry, cell biology and computational chemistry techniques, the team tested a number of antiviral drugs approved by the U.S. Food and Drug Administration (FDA) in a cellular infection model. They discovered simeprevir can simultaneously target two major viral proteins that are critical to viral replication, which are main protease Mpro and RNA polymerase. Simeprevir is by now the only antiviral drug that can target more than one SARS-CoV-2 protein.

 

Professor Billy Wai Lung NG, Assistant Professor of the School of Pharmacy at CU Medicine elaborated, “Simeprevir is an antiviral agent used for the treatment of hepatitis C by inhibiting the activity of viral protease so as to suppress viral replication. Though the drug has already been replaced by other treatment methods for hepatitis C patients, repurposing existing FDA-approved therapeutic agents can shorten the time frame for clinical trials and may reveal new drug targets that can be further exploited. This is indeed a very promising and encouraging discovery. Besides, the chance that the virus develops simultaneous mutations on both of the two viral proteins main protease Mpro and RNA polymerase is low, thus there is less chance to develop drug-resistant mutants.”

 

Drug combination enhances therapeutic potential

 

While remdesivir is effective, it only targets one major viral protein, meaning that remdesivir-resistant viral mutants may emerge. The drug also suffers from drawbacks such as low efficacy against severely ill patients.

 

Dr. Michael Chi Wai CHAN, Associate Professor of the School of Public Health from HKUMed said, “We evaluated the antiviral effect of simeprevir together with remdesivir, and were delighted to observe drug synergism. The viral infection experiments performed at the P3 laboratory in HKUMed demonstrated that with 3.3 μMof remdesivir and simeprevir, the antiviral effect was increased over 100-fold when compared with remdesivir alone.”

 

Professor Ng added, “This not only implies a larger therapeutic window for simeprevir, but also provides mechanistic insights into the interplay between the drugs, giving rise to additional pathways into fighting the virus. Science has no borders. This highly collaborative and interdisciplinary project has shown that the team spirit, determination, and persistence of the researchers are keys to important scientific discovery.”

 

Professor David Shu Cheong HUI, Stanley Ho Professor of Respiratory Medicine at CU Medicine said, “With the development of new vaccines around the world, there seems to be light at the end of the tunnel for the global COVID-19 pandemic. However, the virus remains rampant, with high infection rates in many countries. Recent research studies suggest that the existing vaccines and drugs may not be able to combat the emerging mutants of the virus effectively. Moreover, the recurring coronavirus epidemics in the last two decades suggest that the virus may become a persistent healthcare issue threatening global health. It is therefore essential to enlarge our therapeutic box in preparation for future coronavirus pandemics.” 

Prof. Billy Ng

Professor Billy NG says the findings on simeprevir provides mechanistic insights into the interplay between simeprevir and remdesivir, giving rise to additional pathways into fighting the virus.

Dr. Samuel Chan

Dr. Michael CHAN says the research team has started animal model study and hoping for a preliminary result in six months.

Prof. David Hui

Professor David HUI says if simeprevir is proved to be effective in suppressing of SAR-CoV-2 in clinical trial, the combination of it with remdesivir may shorten the treatment time and encourage further investigation on death rate and other potential benefits. 

More Press Releases

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

Research
A joint HKU-CUHK study finds that smoking  increases the risk of COVID-19

A joint HKU-CUHK study finds that smoking increases the risk of COVID-19

Research
CUHK-HKU collaborative research finds a new inflammatory activation pathway in  blood vessels after SARS-CoV-2 infection

CUHK-HKU collaborative research finds a new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Research
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
CUHK and HKU's Collaborative Research Discovers Novel Epilepsy Genetic Markers

CUHK and HKU's Collaborative Research Discovers Novel Epilepsy Genetic Markers

Research
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CUHK study advises residential care homes for the elderly to maintain current infection control practices

CUHK study advises residential care homes for the elderly to maintain current infection control practices

Research
CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

Research
CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

Research
CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

Health Campaign
CU Medicine study shows distinct gut microbial profile associated with long COVID

CU Medicine study shows distinct gut microbial profile associated with long COVID

Research
Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Research
HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

Research
CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise  Performance of COVID-19 Nucleic Acid Tests

CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise Performance of COVID-19 Nucleic Acid Tests

Research
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

CUHK Study Finds Half of Childhood Cancer Survivors Used Complementary and Alternative Medicine

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Study Suggests Preoperative Screening for Obstructive Sleep Apnoea to  Lower Risk of Postoperative Cardiovascular Events

CUHK Study Suggests Preoperative Screening for Obstructive Sleep Apnoea to Lower Risk of Postoperative Cardiovascular Events

Research
10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

10th Palliative Care Symposium for Healthcare Workers in Chinese Population: ‘Succession ‧ Innovation’

Symposium
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Proves Efficacy of Home-Based Management Approach of Obstructive Sleep Apnoea Applicable to 50% of Public Hospital Adult Cases with Waiting Time Reduced by 80%

CUHK Proves Efficacy of Home-Based Management Approach of Obstructive Sleep Apnoea Applicable to 50% of Public Hospital Adult Cases with Waiting Time Reduced by 80%

Research
The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

The 9th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Integrating Palliative Care into General Care: Paving the Way for the Future’

Symposium
The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

The 8th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Advancing Palliative Care in Hong Kong: Opportunities and Challenges’

Symposium
Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Asia’s First Research by CUHK on Patients’ Lifestyle Reveals Personalised Modification Programme Effective in Reducing Severity of OSA

Research
CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

CUHK Highlights the Significance of Hospital Infection Control System in Controlling MERS

Research
CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

CUHK Estimates Local Smokers Spend over HKD1 Million on Tobacco in Life

Research
CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

CUHK Advocates Atrial Fibrillation Screening and Drug Education to Reduce Risk of Stroke among Elderly

Clinical service
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

The 6th Palliative Care Symposium for Health Care Workers in Chinese Population: ‘Palliative Care for Geriatric Cancer Patients’

Symposium
CUHK will hold 'SARS A Decade On: A Conference for the Health Professionals'

CUHK will hold 'SARS A Decade On: A Conference for the Health Professionals'

Symposium
CUHK Research Reveals Outreach Programme can Ease Drug-related Problems and Improve Quality of Life among Hidden Elders

CUHK Research Reveals Outreach Programme can Ease Drug-related Problems and Improve Quality of Life among Hidden Elders

Research
CUHK Research Findings on Severe Human Swine Flu in Hong Kong

CUHK Research Findings on Severe Human Swine Flu in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.